<DOC>
	<DOC>NCT00666809</DOC>
	<brief_summary>There is incidental evidence (casuistic findings) that the treatment with vardenafil of male patients suffering from erectile dysfunction and comorbid tinnitus experienced an improvement of their tinnitus. Randomized, parallel-group, double-blind, placebo-controlled trial over 16 weeks (12 weeks of treatment + 4 weeks follow-up) with 10 mg vardenafil BID p.o. in men and women with chronic tinnitus.</brief_summary>
	<brief_title>Vardenafil in Tinnitus</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Chronic subjective cochlear tinnitus No treatment of tinnitus within 4 weeks prior to study entry Duration of tinnitus &gt; 3 months Acute tinnitus Intermittent tinnitus History of M. Menier√© History of conductive deafness History of psychogenic deafness History of tumors of the middle ear, inner ear or cerebellapontine angle (malignant and non malignant) Patients diagnosed of multiple sclerosis History of myocardial infarction, stroke, or lifethreatening arrhythmia within the prior 6 months Nitrates or nitric oxide donors Any other concurrent treatment of tinnitus during study pregnant and breastfeeding women women with childbearing potential not using adequate birth control method (Note: as adequate method of birth control oral contraception, spiral or sexual abstinence is recommended) Other exclusion criteria apply according to the Summary of Product Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Vardenafil,</keyword>
	<keyword>Tinnitus</keyword>
</DOC>